1. Home
  2. KNSA vs COLM Comparison

KNSA vs COLM Comparison

Compare KNSA & COLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • COLM
  • Stock Information
  • Founded
  • KNSA 2015
  • COLM 1938
  • Country
  • KNSA United Kingdom
  • COLM United States
  • Employees
  • KNSA N/A
  • COLM N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • COLM Apparel
  • Sector
  • KNSA Health Care
  • COLM Consumer Discretionary
  • Exchange
  • KNSA Nasdaq
  • COLM Nasdaq
  • Market Cap
  • KNSA 2.6B
  • COLM 2.7B
  • IPO Year
  • KNSA 2018
  • COLM 1998
  • Fundamental
  • Price
  • KNSA $41.77
  • COLM $53.23
  • Analyst Decision
  • KNSA Strong Buy
  • COLM Hold
  • Analyst Count
  • KNSA 6
  • COLM 9
  • Target Price
  • KNSA $51.33
  • COLM $61.13
  • AVG Volume (30 Days)
  • KNSA 461.3K
  • COLM 758.0K
  • Earning Date
  • KNSA 10-28-2025
  • COLM 10-30-2025
  • Dividend Yield
  • KNSA N/A
  • COLM 2.25%
  • EPS Growth
  • KNSA N/A
  • COLM N/A
  • EPS
  • KNSA 0.47
  • COLM 3.37
  • Revenue
  • KNSA $597,973,000.00
  • COLM $3,423,711,000.00
  • Revenue This Year
  • KNSA $62.63
  • COLM $1.70
  • Revenue Next Year
  • KNSA $29.93
  • COLM $1.87
  • P/E Ratio
  • KNSA $89.00
  • COLM $15.84
  • Revenue Growth
  • KNSA 55.68
  • COLM 2.75
  • 52 Week Low
  • KNSA $17.82
  • COLM $47.47
  • 52 Week High
  • KNSA $42.93
  • COLM $92.88
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 64.60
  • COLM 53.53
  • Support Level
  • KNSA $39.61
  • COLM $49.57
  • Resistance Level
  • KNSA $42.93
  • COLM $54.76
  • Average True Range (ATR)
  • KNSA 1.43
  • COLM 1.74
  • MACD
  • KNSA 0.19
  • COLM -0.01
  • Stochastic Oscillator
  • KNSA 79.30
  • COLM 69.30

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. Columbia sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

Share on Social Networks: